IL13RA2 and glioblastoma: Besides, trivalent T-cell product, known as universal tricistronic transgene (UCAR) T cells, which armed with three CAR molecules detecting HER2, IL-13 receptor subunit alpha-2 (IL13Rα2), and ephrin-A2 (EphA2), has showed promising outcomes for GBM therapy [115].